Logo Image
Opinion|Videos|April 25, 2025

Closing Perspectives

Experts discuss how to evaluate the cost-effectiveness of continuous glucose monitoring (CGM) compared to traditional monitoring, considering both clinical and quality outcomes, and what combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations.

Episodes in this series

Video content above is prompted by the following:

  1. How do you evaluate the cost-effectiveness of CGM compared to traditional monitoring when considering both clinical and quality outcomes?
  2. What: combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations?

Related Content